|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/29 | (2006.01) |
| A61K 33/10 | (2006.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2682124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13181713.2 |
| Date of filing the European patent application | 2010-09-08 | |
| (97) | Date of publication of the European application | 2014-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2009208039 | 2009-09-09 | JP |
| (72) |
Shirae, Shinichiro., JP
Nakamura, Yasuo., JP
Oya, Yuiko., JP
Nozaki, Yoshihide, JP
Kobayashi, Nobuyuki., JP
Kuroda, Tatsuhiko., JP
Kato, Hiroki., JP
Serada, Masashi., JP
Hori, Kazuyoshi., JP
|
| (73) |
Asahi Kasei Pharma Corporation,
1-105 Kanda Jinbocho Chiyoda-ku, Tokyo 101-8101,
JP
|
| (54) | PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |
| PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |